Publications by authors named "Sudeepta Aggarwal"

Claim this Profile
E
Effect of Hepatic Impairment on the Pharmacokinetics of Nirmatrelvir/Ritonavir, the First Oral Protease Inhibitor for the Treatment of COVID-19.
Ravi Shankar P Singh, Robert R LaBadie, Sima S Toussi, Haihong Shi, Jolene Kay Berg, Sudeepta Aggarwal

J Clin Pharmacol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Intravenous Infusions of PF-07304814 (Lufotrelvir) in Participants Hospitalized With COVID-19.
Philip Robinson, Sima S Toussi, Sudeepta Aggarwal, Arthur Bergman, Tong Zhu

Open Forum Infect Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis: a phase IIb randomized double-blind vehicle-controlled parallel-group study.
Megan N Landis, Stacy R Smith, Gabriel Berstein, Gerald Fetterly, Pranab Ghosh, Sudeepta Aggarwal

Br J Dermatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of topical brepocitinib for the treatment of mild-to-moderate atopic dermatitis: a phase IIb, randomized, double-blind, vehicle-controlled, dose-ranging and parallel-group study.
Megan N Landis, Mark Arya, Stacy Smith, Zoe Draelos, Lisa Usdan, Sudeepta Aggarwal

Br J Dermatol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials.
Roberto A Calle, Neeta B Amin, Santos Carvajal-Gonzalez, Trenton T Ross, Arthur Bergman, Sudeepta Aggarwal, Naresh Aggarwal

Nat Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial.
Mark R Rigby, Linda A DiMeglio, Marc S Rendell, Eric I Felner, Jean M Dostou, Sudeepta Aggarwal

Lancet Diabetes Endocrinol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial.
Stephen E Gitelman, Peter A Gottlieb, Mark R Rigby, Eric I Felner, Steven M Willi, Sudeepta Aggarwal

Lancet Diabetes Endocrinol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders.
Kevan C Herold, Stephen E Gitelman, Mario R Ehlers, Peter A Gottlieb, Carla J Greenbaum, Sudeepta Aggarwal

Diabetes· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function.
S Alice Long, Mary Rieck, Srinath Sanda, Jennifer B Bollyky, Peter L Samuels, Sudeepta Aggarwal

Diabetes· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma.
Paul A Moore, Wenjun Zhang, G Jonah Rainey, Steve Burke, Hua Li, Sudeepta Aggarwal

Blood· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune modulator CD70 as a potential cisplatin resistance predictive marker in ovarian cancer.
Sudeepta Aggarwal, Tao He, William Fitzhugh, Kim Rosenthal, Brian Feild

Gynecol Oncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human mesenchymal stem cells modulate allogeneic immune cell responses.
Sudeepta Aggarwal, Mark F Pittenger

Blood· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17.
Sudeepta Aggarwal, Nico Ghilardi, Ming-Hong Xie, Frederic J de Sauvage, Austin L Gurney

J Biol Chem· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-17: prototype member of an emerging cytokine family.
Sudeepta Aggarwal, Austin L Gurney

J Leukoc Biol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis